Heart Teams for Aortic Valve Disease: The TAVI Revolution

  • Talal Al-AtassiEmail author
  • Marino Labinaz


Severe aortic valve stenosis is associated with poor prognosis without intervention. Surgical aortic valve replacement was the standard intervention until the advent of transcatheter aortic valve implantation in 2002. The last two decades witnessed a rapid evolution in decision-making, technology and techniques. Concurrently, patients with aortic stenosis are becoming increasingly more complex. A multidisciplinary “Heart Team” facilitates navigation through a complex and continually evolving decision-making environment. This chapter explores the history, composition, role, benefits, challenges, and future of the Heart Team evaluating aortic stenosis in general with specific anecdotes as it applies to the authors’ center: The University of Ottawa Heart Institute (UOHI) in Ottawa, Canada.


Aortic valve stenosis (AS) Surgical aortic valve replacement (SAVR) Transcatheter aortic valve implantation (TAVI) SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) PARTNER (Placement of Aortic Transcatheter Valves) 


  1. 1.
    d’Arcy JL, Coffey S, Loudon MA, Kennedy A, Pearson-Stuttard J, Birks J, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J. 2016;37(47):3515–22.CrossRefGoogle Scholar
  2. 2.
    Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. The Tromso study. Heart. 2013;99(6):396–400.CrossRefGoogle Scholar
  3. 3.
    Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002–12.CrossRefGoogle Scholar
  4. 4.
    Clark MA, Arnold SV, Duhay FG, Thompson AK, Keyes MJ, Svensson LG, et al. Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis. Circ Cardiovasc Qual Outcomes. 2012;5(5):697–704.CrossRefGoogle Scholar
  5. 5.
    Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.CrossRefGoogle Scholar
  6. 6.
    Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–8.CrossRefGoogle Scholar
  7. 7.
    Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.CrossRefGoogle Scholar
  8. 8.
    Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.CrossRefGoogle Scholar
  9. 9.
    Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–31.CrossRefGoogle Scholar
  10. 10.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–e132.CrossRefGoogle Scholar
  11. 11.
    Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42(4):S1–44.CrossRefGoogle Scholar
  12. 12.
    Webb J, Rodés-Cabau J, Fremes S, Pibarot P, Ruel M, Ibrahim R, et al. Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement. Can J Cardiol. 2012;28(5):520–8.CrossRefGoogle Scholar
  13. 13.
    Croke JM, El-Sayed S. Multidisciplinary management of cancer patients: chasing a shadow or real value? An overview of the literature. Curr Oncol. 2012;19(4):e232–8.CrossRefGoogle Scholar
  14. 14.
    Freeman RK, Van Woerkom JM, Vyverberg A, Ascioti AJ. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer. Eur J Cardiothorac Surg. 2010;38(1):1–5.CrossRefGoogle Scholar
  15. 15.
    Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13,722 women. BMJ. 2012;344:e2718.CrossRefGoogle Scholar
  16. 16.
    Taylor C, Munro AJ, Glynne-Jones R, Griffith C, Trevatt P, Richards M, et al. Multidisciplinary team working in cancer: what is the evidence? BMJ. 2010;340:c951.CrossRefGoogle Scholar
  17. 17.
    Del Sindaco D, Pulignano G, Minardi G, Apostoli A, Guerrieri L, Rotoloni M, et al. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure. J Cardiovasc Med (Hagerstown). 2007;8(5):324–9.CrossRefGoogle Scholar
  18. 18.
    Ducharme A, Doyon O, White M, Rouleau JL, Brophy JM. Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial. CMAJ. 2005;173(1):40–5.CrossRefGoogle Scholar
  19. 19.
    Takeda A, Taylor SJ, Taylor RS, Khan F, Krum H, Underwood M. Clinical service organisation for heart failure. Cochrane Database Syst Rev. 2012;(9):CD002752.Google Scholar
  20. 20.
    Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–72.CrossRefGoogle Scholar
  21. 21.
    Forcillo J, Condado JF, Ko YA, Yuan M, Binongo JN, Ndubisi NM, et al. Assessment of commonly used frailty markers for high- and extreme-risk patients undergoing transcatheter aortic valve replacement. Ann Thorac Surg. 2017;104(6):1939–46.CrossRefGoogle Scholar
  22. 22.
    Lauck SB, Wood DA, Baumbusch J, Kwon JY, Stub D, Achtem L, et al. Vancouver transcatheter aortic valve replacement clinical pathway: minimalist approach, standardized care, and discharge criteria to reduce length of stay. Circ Cardiovasc Qual Outcomes. 2016;9(3):312–21.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.University of Ottawa Heart Institute, Department of Surgery, Division of Cardiac SurgeryOttawaCanada
  2. 2.University of Ottawa Heart Institute, Division of CardiologyOttawaCanada

Personalised recommendations